Alpha Dna Investment Management LLC Edwards Lifesciences Corp Transaction History

Alpha Dna Investment Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	SELL	$69.28 - $93.38 $765,959 - $1.03 Million	-11,056 Reduced 76.53%	3,390 $234,000
Q2 2023 Jul 31, 2023	BUY	$81.41 - $94.33 $1.18 Million - $1.36 Million	14,446 New	14,446 $1.36 Million
Q2 2021 Aug 10, 2021	SELL	$83.84 - $104.76 $3,437 - $4,295	-41 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$78.68 - $90.67 $5,350 - $6,165	-68 Reduced 62.39%	41 $3,000
Q4 2020 Feb 16, 2021	BUY	$71.69 - $91.23 $7,814 - $9,944	109 New	109 $9,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Alpha Dna Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Dna Investment Management LLC with notifications on news.